Indian pharmaceutical companies have tried to defend their turf through aggressive pricing for long. They are now getting a taste of the same medicine from Big Pharma.Pharma multinationals are......
A sharp increase in interest costs has caused Glenmark Pharmaceuticals to post a consolidated net profit of Rs 80.9 crore for the second quarter, 31 percent lower than the Rs 117.3 crore for the......
After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to......
India's leading drug-maker Ranbaxy on Wednesday said it has acquired Terapia, the largest independent generic company in Romania, for $324 million and aims to make that country its manufacturing......